Amyloid-beta peptide-specific single chain Fv antibodies isolated from an immune phage display library

Journal of Neuroimmunology

Volumn 145, Issue 1-2, 2003, Pages 12-17

  Manoutcharian, K ^a   Acero, G ^a   Munguia, M E ^a   Montero, J A ^a   Govezensky, T ^a   Cao, C ^b   Ugen, K ^b   Gevorkian, G ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Alzheimer's disease; Phage display; Single chain fragment variable (scFv) antibody library

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANTIBODY ISOLATION; ARTICLE; COMPLEMENTARITY DETERMINING REGION; COMPUTER ANALYSIS; CONTROLLED STUDY; GENE SEGREGATION; GENE SEQUENCE; GENETIC ANALYSIS; IMMUNE RESPONSE; IMMUNOGLOBULIN VARIABLE REGION; MOLECULAR CLONING; MOUSE; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; SPLEEN CELL;

EID: 0345303883     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2003.08.038     Document Type: Article

References (30)

1. Bacskai B.J., Kajdasz S.T., McLellan M.E., Games D., Seubert P., Schenk D., Hyman B.T. Non-Fc-mediated mechanisms are involved in clearance of amyloid-β in vivo by immunotherapy. J. Neurosci. 22:2002;7873-7878.
2. Bard F., Cannon C., Barbour R., Burke R.-L., Games D., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Lieberburg I., Motter R., Nguyen M., Soriano F., Vasquez N., Weiss K., Welch K., Seubert P., Schenk D., Yednock T.Peripherally administered antibodies against amyloid-β peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer's disease.™ Nat. Med. 6:2000;916-919.
3. Bitan G., Kirkitadze M.D., Lomakin A., Vollers S.S., Benedek G.B., Teplow D.B. Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways. Proc. Natl. Acad. Sci. U. S. A. 100:2003;330-335.
4. Carcamo J., Ravera M.W., Brissette R., Dedova O., Beasley J.R., Alam-Moghr A., Wan C., Blume A., Mandecki W. Unexpected frameshifts from gene to expressed protein in a phage-displayed peptide library. Proc. Natl. Acad. Sci. U. S. A. 95:1998;11146-11151.
5. Demeester N., Mertens C., Caster H., Goethals M., Vandekerckhove J., Rosseneu M., Labeur C. Comparison of the aggregation properties, secondary structure and apoptotoc effects of wild-type, Flemish and Dutch N-terminally truncated amyloid β peptides. Eur. J. Neurosci. 13:2001;2015-2024.
6. Dodart J.C., Bales K.R., Gannon K.S., Greene S.J., DeMattos R.B., Mathis C., DeLong C.A., Wu S., Wu X., Holtzman D.M., Paul S.M. Immunization reverses memory deficits reducing Aβ burden in Alzheimer's disease model. Nat. Neurosci. 5:2002;452-457.
7. Frenkel D., Solomon B. Filamentous phage as vector-mediated antibody delivery to the brain. Proc. Natl. Acad. Sci. U. S. A. 99:2002;5675-5679.
8. Frenkel D., Solomon B., Benhar I. Modulation of Alzheimer's β-amyloid neurotoxicity by site-directed single-chain antibody. J. Neuroimmunol. 106:2000;23-31.
9. Gaskin F., Finley J., Fang Q., Xu S., Fu S.M. Human antibodies reactive with β-amyloid protein in Alzheimer's disease. J. Exp. Med. 177:1993;1181-1186.
10. Gevorkian G., Manoutcharian K., Almagro J.C., Govezensky T., Dominguez V. Identification of autoimmune thrombocytopenic purpura-related epitopes using phage-display peptide library. Clin. Immunol. Immunopathol. 86:1998;305-309.
11. Gevorkian G., Manoutcharian K., Govezensky T., Cano A., Dominguez V., Santamaria H., Larralde C. Identification of mimotopes of platelet autoantigens associated with autoimmune thrombocytopenic purpura. J. Autoimmun. 15:2000;33-40.
12. Gouras G.K., Tsai J., Naslund J., Vincent B., Edgar M., Checler F., Greenfield J.P., Haroutunian V., Buxbaum J.D., Xu H., Grenngard P., Relkin N.R. Intraneuronal Aβ42 accumulation in human brain. Am. J. Pathol. 156:2000;15-20.
13. Hock C., Konietzko U., Streffer J.R., Tracy J., Signorell A., Muller-Tillmanns B., Lemke U., Henke K., Moritz E., Garcia E., Wollmer M.A., Umbricht D., de Quervain D.J.F., Hofmann M., Maddalena A., Papassotiropoulos A., Nitsch R.M. Antibodies against β-amyloid slow cognitive decline in Alzheimer's disease. Neuron. 38:2003;1-20.
14. Janus C., Pearson J., McLaurin J., Mathews P.M., Jiang Y., Schmidt S.D., Azhar Chishti M., Horne P., Heslin D., French J., Mount H.T.J., Nixon R.A., Mercken M., Bergeron C., Fraser P.E., St.George-Hyslop P., Westaway D. Aβ peptide immunization reduces behavioral impairment and plaques in a model of Alzheimer's disease. Nature. 408:2000;979-982.
15. Lecerf J.-M., Shirley T.L., Zhu Q., Kazantsev A., Amersdorfer P., Housman D.E., Mecer A., Huston J.S. Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease. Proc. Natl. Acad. Sci. U. S. A. 98:2001;4764-4769.
16. Lue L.F., Walker D.G. Modeling Alzheimer's disease immune therapy mechanisms: interactions of human postmortem microglia with antibody-opsonized amyloid-β peptide. J. Neurosci. Res. 70:2002;599-610.
17. Ma B., Nussinov R. Stabilities and conformations of Alzheimer's β-amyloid peptide oligomers (Aβ 16-22, Aβ 16-35, and Aβ 10-35): sequence effects. Proc. Natl. Acad. Sci. U. S. A. 99:2002;14126-14131.
18. MacBeath G., Kast P. UGA read-through artifacts - when popular gene expression systems need a pATCH. BioTechniques. 24:1998;789-794.
19. Manoutcharian K., Sotelo J., Garcia E., Cano A., Gevorkian G. Characterization of cerebrospinal fluid antibody specificities in neurocysticercosis using phage display peptide library. Clin. Immunol. 91:1999;117-121.
20. Mohajeri M.H., Sainin K., Schultz J.G., Wollmer M.A., Hock C., Nitsch R.M. Passive immunization against β-amyloid peptide protects central nervous system (CNS) neurons from increased vulnerability associated with an Alzheimer's disease-causing mutation. J. Biol. Chem. 277:2002;33012-33017.
21. Morgan D., Diamond D.M., Gottschall P.E., Ugen K., Dickey C., Hardy J., Duff K., Jantzen P., DiCarlo G., Wilcock D., Connor K., Hatcher J., Hope C., Gordon M., Arendash G.W. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature. 408:2000;982-985.
22. Munch G., Robinson R. Potential neurotoxic inflammatory responses to Aβ vaccination in humans. J. Neural Transm. 109:2002;1081-1087.
23. Pfeifer M., Boncristiano S., Bondolfi L., Stalder A., Séller T., Staufenbiel M., Mathews P.M., Jucker M. Cerebral hemorrhage after passive anti-Aβ immunotherapy. Science. 298:2002;1379.
24. Pike C.J., Overman M.J., Cotman C.W. Amino-terminal deletions enhance aggregation of β-amyloid peptides in vitro. J. Biol. Chem. 270:1995;23895-23898.
25. Poul M.-A., Becerril B., Nielsen U.B., Morisson P., Marks J.D. Selection of tumor-specific internalizing human antibodies from phage libraries. J. Mol. Biol. 301:2000;1149-1161.
26. Rondot S., Koch J., Breitling F., Dubel S. A helper phage to improve single-chain antibody presentation in phage display. Nat. Biotechnol. 19:2001;75-78.
27. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Liao Z., Lieberburg I., Motter R., Mutter L., Soriano F., Shopp G., Vasquez N., Vandevert C., Walker S., Wogulis M., Yednock T., Games D., Seubert P. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature. 400:1999;173-177.
28. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Phys. Rev. 81:2001;741-766.
29. Solomon B., Koppel R., Frankel D., Hanan-Aharon E. Disaggregation of Alzheimer β-amyloid by site-directed mAb. Proc. Natl. Acad. Sci. U. S. A. 94:1997;4109-4112.
30. Tessmann K., Erhardt A., Haussinger D., Heintges T. Cloning and molecular characterization of human high affinity antibody fragments against Hepatitis C virus NS3 helicase. J. Virol. Methods. 103:2002;75-88.